Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
320 participants
OBSERVATIONAL
2009-12-01
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
NCT06245798
Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma
NCT02145013
Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
NCT01201655
HR Versus RFA for HCC in Patients With PHT
NCT02192671
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)
NCT05703750
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-CSPH
BCLC stage A patients who underwent hepatectomy in the group without clinically significant portal hypertension (Non-CSPH)
hepatectomy
Liver resection
CSPH
BCLC stage A patients who underwent hepatectomy in the group with clinically significant portal hypertension (CSPH)
hepatectomy
Liver resection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hepatectomy
Liver resection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CXPJJH11800001-2018306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.